Companies: 10,795·Total market cap: $144.5T
Prenetics Global Limited

Prenetics Global Limited

PRENASDAQHealthcare● Active
$20.00
+$0.14(+0.70%)
Market Cap$340007860
P/E Ratio
52W High$23.63
52W Low$6.88
Overview

Prenetics Global Limited (PRE) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · PRE · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-4.02pre eps ttm · pre earnings per shareEarnings history
PE Ratio (TTM)pre pe ratio ttm · pre price to earningsPE Ratio deep dive
Revenue (TTM)$95.1Mpre revenue ttm · pre annual revenueFull revenue history
Dividend Yield2.46%does pre pay dividends · pre dividend yieldDividend history
Shares Outstanding14.1Mpre shares outstanding · pre floatShares outstanding history
Next EarningsSep 11, 2026Est.pre earnings date · pre next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$92.4M▲ +201.72% YoY
202320242025
prenetics global limited revenue · pre revenue 2025
FY 2025Net Income-$37.7M▲ +18.56% YoY
202320242025
prenetics global limited net income · pre profit 2025
FY 2025EPS$-2.68▲ +26.37% YoY
202320242025
pre eps · prenetics global limited earnings per share 2025
TTM:Revenue: $95.1MNet Income: -$58.3MEPS: $-4.02View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy1 analystsis pre a buy · pre analyst rating
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$36.00Low
$20.00Current
$36.00Avg Target80.00% upside
$36.00High
pre price target · pre 12 month forecast

Total: 1 · Buy rate: 100.0%

The PRE analyst consensus is Buy, based on ratings from 1 Wall Street analysts over the past 3 months. The average 12-month price target is $36.00, representing +80.00% upside from the current price of $20.00.

Stock Performance

Full History
1D+0.70%
1W-2.49%
1M+23.76%
3M+12.36%
YTD+26.98%
1Y+159.07%
5Y-82.45%

About Prenetics Global Limited

CEOSheng Wu Yeung
IPO DateJul 16, 2021
Employees285
CountryHK

Prenetics Global Limited As an investment holding company, Prenetics Global Limited specializes in providing diagnostic and genetic testing services. Its comprehensive product line features CircleDNA, a consumer-oriented gene…

what is prenetics global limited · pre stock overview · prenetics global limited company profile · who is prenetics global limited ceo · pre NASDAQ · prenetics global limited headquarters · prenetics global limited business segments

About Stock Overview & Key Data

Prenetics Global Limited (PRE) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on NASDAQ since Jul 16, 2021. As of the latest trading session, PRE stock price is $20.00, with a market capitalization of $340.0M. The stock has returned +159.07% over the past 12 months and +26.98% year-to-date.

According to 1 Wall Street analysts, the consensus rating for Prenetics Global Limited stock is Buy, with an average 12-month price target of $36.00. In fiscal year 2025, Prenetics Global Limited reported revenue of $92.4M and net income of -$37.7M. For detailed data — including Prenetics Global Limited revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Prenetics Global Limited (PRE) stock price is $20.00. The stock is traded on NASDAQ under the ticker symbol PRE. The 52-week range is $6.88 – $23.63.

PRE stock pricePRE quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice